Vir Biotechnology
Stock Forecast, Prediction & Price Target
Vir Biotechnology Financial Estimates
Vir Biotechnology Revenue Estimates
Vir Biotechnology EBITDA Estimates
Vir Biotechnology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.08B N/A | $1.58B 45.38% | $86.18M -94.54% | Avg: $38.54M Low: $12.51M High: $62.91M avg. -55.27% | Avg: $55.80M Low: $32.38M High: $92.80M avg. 44.78% | Avg: $212.47M Low: $123.30M High: $353.34M avg. 280.75% | Avg: $243.43M Low: $141.26M High: $404.82M avg. 14.57% |
Net Income
% change YoY
| $528.58M N/A | $515.83M -2.41% | $-615.06M -219.23% | Avg: $-579.15M Low: $-623.70M High: $-415.80M avg. 5.83% | Avg: $-605.57M Low: $-623.70M High: $-285.69M avg. -4.56% | Avg: $-377.91M Low: $-703.62M High: $-171.72M avg. 37.59% | Avg: $-397.47M Low: $-740.04M High: $-180.61M avg. -5.17% |
EBITDA
% change YoY
| $282.70M N/A | $944.20M 233.99% | $-664.85M -170.41% | Avg: $-16.51M Low: $-26.95M High: $-5.36M avg. 97.51% | Avg: $-23.91M Low: $-39.76M High: $-13.87M avg. -44.78% | Avg: $-91.04M Low: $-151.40M High: $-52.83M avg. -280.75% | Avg: $-104.31M Low: $-173.46M High: $-60.53M avg. -14.57% |
EPS
% change YoY
| $4.07 N/A | $3.89 -4.42% | -$4.59 -217.99% | Avg: -$3.94 Low: -$4.65 High: -$3.1 avg. 14.21% | Avg: -$3.52 Low: -$4.65 High: -$2.13 avg. 10.48% | Avg: -$2.82 Low: -$5.25 High: -$1.28 avg. 20.06% | Avg: -$2.96 Low: -$5.52 High: -$1.35 avg. -5.17% |
Operating Expenses
% change YoY
| $600.45M N/A | $601.08M 0.10% | $767.72M 27.72% | Avg: $433.26M Low: $140.71M High: $707.24M avg. -43.56% | Avg: $627.28M Low: $364.02M High: $1.04B avg. 44.78% | Avg: $2.38B Low: $1.38B High: $3.97B avg. 280.75% | Avg: $2.73B Low: $1.58B High: $4.55B avg. 14.57% |
FAQ
What is Vir Biotechnology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 8.42% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -623.70M, average is -579.15M and high is -415.80M.
What is Vir Biotechnology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 71.20% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $12.51M, average is $38.54M and high is $62.91M.
What is Vir Biotechnology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 9.89% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$4.65, average is -$3.94 and high is $-3.1.
What is the best performing analyst?
In the last twelve months analysts have been covering Vir Biotechnology stock. The most successful analyst is Michael Ulz.